Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Il-Yang Quadrivalent Influenza Vaccine in Healthy Children and Adolescents
NCT03445468Phase 3Completed
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Sep 2017
- Primary completion
- Dec 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent influenza vaccine in influenza, sponsored by Il-Yang Pharmaceutical. Started Sep 2017; status: completed.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03445468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03445468.